
Pictured is the team from the Tissue Engineering Research Group (TERG) who won four awards at the recent 2016 Bioengineering in Ireland Conference. The TERG is a cross departmental research group at RCSI that includes Anatomy, Molecular Cellular Therapeutics (MCT), Chemistry and the School of Pharmacy in addition to clinical departments in orthopaedics & ophthalmology, have reinforced their status as leaders in their field by presenting a series of studies and winning a number of significant awards at the 22nd Annual Conference of the Section of Bioengineering of Royal Academy of Medicine in Ireland (Bioengineering in Ireland), which was held in Salthill Hotel, Galway, on the 22nd and 23rd of January. This year’s Bioengineering in Ireland conference was the largest ever with over 250 interdisciplinary attendees presenting over 180 papers and thus greater competition than ever for these awards.